Geneva Health Forum

7th Edition: Precision Global Health in the Digital Age

April 10-12, 2018
Geneva, Switzerland
The call for contributions is now open until 15th September 2018.

The search for treatments for HIV/VL co-infected patients continues

HIV-VL patient with nurseVisceral Leishmaniasis

Thirty-five year old Tsadik is a visceral leishmaniasis (VL) patient who is also infected with HIV. He is gaunt, weak and tired, with sunken eyes. Each breath he takes is laboured. Tsadik lives in Abdurafi, a region of northwest Ethiopia that is characterized with high VL-HIV co-infection because VL is endemic….

ASTMH 2017

66th Annual Meeting
November 5-9, 2017
Baltimore, Maryland, USA
DNDi will be presenting on Chagas disease.

Yomiuri Online [20 April, 2017]

“DNDiの「創薬ブースター」コンソーシアムに、メルク社(ドイツ)が新たに参加 -顧みられない病気の創薬を加速する” – “Merck AG (Germany) newly participates in DNDi‘s “Drug Discovery Booster” consortium”